Syros Pharmaceuticals, Inc. (SYRS)
0.0005
0.00 (0.00%)
USD |
OTCM |
Dec 16, 15:57
Syros Pharmaceuticals EPS Diluted (Quarterly): -0.1626 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Trevena, Inc. | -5.792 |
| Cantabio Pharmaceuticals, Inc. | -- |
| Q BioMed, Inc. | -- |
| Affymax, Inc. | -- |
| Scopus Biopharma, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.396M |
| Total Expenses (Quarterly) | 6.396M |